2011•China Medical HeraldRequires access

Clinical observation of Levofloxacin in treating 30 cases with mycoplasmal pneumonia

Zhang Tiebiao

Open publisher page 0 citations

Abstract

Objective:To investigate the effective treatment method of mycoplasmal pneumonia and to choose antibiotics reasonably.Methods:Clinical data of 52 cases with mycoplasmal pneumonia from January 2009 to December 2010 were collected and arranged,which were retrospectively analyzed.There were 22 cases in Azithromycin group,30 cases in Levofloxacin group.The clinical curative effect of Azithromycin and Levofloxacin were analyzed.Results:The drug resistance of Azithromycin was increased,temperature of Azithromycin group was decreased slowly,and temperature of Levofloxacin group was decreased significantly,there was a statistically significant difference of the temperature between the two groups(P0.05).The total effective rate of lung imaging absorption of Azithromycin group was 63.64%,which of Levofloxacin group was 100.00%,there was a statistically significant difference(χ2=15.432,P0.01).Conclusion:Clinical effect of mycoplasmal pneumonia in the treatment with Levofloxacin is better than Azithromycin,it is worthy of promotion in clinic.

About this research paper

What this paper is about

Objective:To investigate the effective treatment method of mycoplasmal pneumonia and to choose antibiotics reasonably.Methods:Clinical data of 52 cases with mycoplasmal pneumonia from January 2009 to December 2010 were collected and arranged,which were retrospectively analyzed.There were 22 cases in Azithromycin group,30 cases in Levofloxacin group.The clinical curative effect of Azithromycin and Levofloxacin were analyzed.Results:The drug resistance of Azithromycin was increased,temperature of Azithromycin group was decreased slowly,and temperature of Levofloxacin group was decreased significantly,there was a statistically significant difference of the temperature between the two groups(P0.05).The total effective rate of lung imaging absorption of Azithromycin group was 63.64%,which of Levofloxacin group was 100.00%,there was a statistically significant difference(χ2=15.432,P0.01).Conclusion:Clinical effect of mycoplasmal pneumonia in the treatment with Levofloxacin is better than Azithromycin,it is worthy of promotion in clinic.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effective treatment method of mycoplasmal pneumonia and to choose antibiotics reasonably.Methods:Clinical data of 52 cases with mycoplasmal pneumonia from January 2009 to December 2010 were collected and arranged,which were retrospectively analyzed.There were 22 cases in Azithromycin group,30 cases in Levofloxacin group.The clinical curative effect of Azithromycin and Levofloxacin were analyzed.Results:The drug resistance of Azithromycin was increased,temperature of Azithromycin group was decreased slowly,and temperature of Levofloxacin group was decreased significantly,there was a statistically significant difference of the temperature between the two groups(P0.05).The total effective rate of lung imaging absorption of Azithromycin group was 63.64%,which of Levofloxacin group was 100.00%,there was a statistically significant difference(χ2=15.432,P0.01).Conclusion:Clinical effect of mycoplasmal pneumonia in the treatment with Levofloxacin is better than Azithromycin,it is worthy of promotion in clinic.

Key concepts: Azithromycin, Levofloxacin, Medicine, Pneumonia, Internal medicine, Antibiotics, Microbiology, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of Levofloxacin in treating 30 cases with mycoplasmal pneumonia — Research Paper | ScholarLens